Stockreport

ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably [Seeking Alpha]

ProKidney Corp. - Class A Ordinary Shares  (PROK) 
PDF The FDA also accepted using eGFR slope analysis for evaluating its potential accelerated approval. PROK believes they'll be ready with their topline slope analysis by [Read more]